דיקלקטין ישראל - עברית - Ministry of Health

דיקלקטין

tzamal bio-pharma ltd - doxylamine succinate; pyridoxine (vit b6) hydrochloride - טבליות שחרור מושהה - pyridoxine (vit b6) hydrochloride 10 mg; doxylamine succinate 10 mg - doxylamine

לדוקסיה טבע ישראל - עברית - Ministry of Health

לדוקסיה טבע

teva israel ltd - doxylamine succinate; pyridoxine (vit b6) hydrochloride - טבליות שחרור מושהה - pyridoxine (vit b6) hydrochloride 10 mg; doxylamine succinate 10 mg - doxylamine combinations

סיפרול 1 מג ישראל - עברית - Ministry of Health

סיפרול 1 מג

boehringer ingelheim israel ltd. - pramipexole dihydrochloride monohydrate - טבליה - pramipexole dihydrochloride monohydrate 1 mg - pramipexole - pramipexole - treatment of signs and symptoms of idiopathic parkinson's disease, as monotherapy or in combination with lovodopa.

סיפרול 0.25 מג ישראל - עברית - Ministry of Health

סיפרול 0.25 מג

boehringer ingelheim israel ltd. - pramipexole dihydrochloride monohydrate - טבליה - pramipexole dihydrochloride monohydrate 0.25 mg - pramipexole - pramipexole - treatment of signs and symptoms of idiopathic parkinson's disease, as monotherapy or in combination with lovodopa. for symptomatic treatment of moderate to severe idiopathic restless legs syndrome.

סיפרול ER 0.375 ישראל - עברית - Ministry of Health

סיפרול er 0.375

boehringer ingelheim israel ltd. - pramipexole dihydrochloride monohydrate - טבליות עם שחרור נרחב - pramipexole dihydrochloride monohydrate 0.375 mg - pramipexole - pramipexole - treatment of signs and symptoms of idiopathic parkinson's disease, as monotherapy or in combination with levodopa.

סיפרול 0.75 ER ישראל - עברית - Ministry of Health

סיפרול 0.75 er

boehringer ingelheim israel ltd. - pramipexole dihydrochloride monohydrate - טבליות עם שחרור נרחב - pramipexole dihydrochloride monohydrate 0.75 mg - pramipexole - pramipexole - treatment of signs and symptoms of idiopathic parkinson's disease, as monotherapy or in combination with levodopa.

סיפרול 1.5 ER ישראל - עברית - Ministry of Health

סיפרול 1.5 er

boehringer ingelheim israel ltd. - pramipexole dihydrochloride monohydrate - טבליות עם שחרור נרחב - pramipexole dihydrochloride monohydrate 1.5 mg - pramipexole - pramipexole - treatment of signs and symptoms of idiopathic parkinson's disease, as monotherapy or in combination with levodopa.

מרוניל 25 ישראל - עברית - Ministry of Health

מרוניל 25

unipharm ltd, israel - clomipramine hydrochloride - טבליה - clomipramine hydrochloride 25 mg - non selective monoamine reuptake inhibitors - depression of varying origin.in children and adolescents there is not sufficient evidence of safety and efficacy of maronil in the treatment of depressive states of varying aetiology and symptomatology. the use of maronil in children and adolescents ( 0 - 17 years of age ) in this indication is therefore not recommended. obsessive compulcive syndromes.no experience is available in children younger than 5 years of age.

רקויפ מודוטאב 2 מ"ג ישראל - עברית - Ministry of Health

רקויפ מודוטאב 2 מ"ג

glaxo smith kline (israel) ltd - ropinirole as hydrochloride 2 mg - film coated tablets - prolonged release - ropinirole - ropinirole is indicated for the treatment of parkinson's disease. ropinirole is effective as early therapy in patients requiring dopaminergic therapy. as adjunctive treatment to l-dopa, ropinirole enhances the efficacy of l-dopa, including control of "on-off" fluctuations and "end of dose" effects associated with chronic l-dopa therapy and permits reduction in daily l-dopa dose.

רקויפ מודוטאב 8 מ"ג ישראל - עברית - Ministry of Health

רקויפ מודוטאב 8 מ"ג

glaxo smith kline (israel) ltd - ropinirole as hydrochloride 8 mg - film coated tablets - prolonged release - ropinirole - ropinirole is indicated for the treatment of parkinson's disease. ropinirole is effective as early therapy in patients requiring dopaminergic therapy. as adjunctive treatment to l-dopa, ropinirole enhances the efficacy of l-dopa, including control of "on-off" fluctuations and "end of dose" effects associated with chronic l-dopa therapy and permits reduction in daily l-dopa dose.